BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33713386)

  • 1. Differential characteristics and outcomes of Asian and non-Asian patients with HBV-related hepatocellular carcinoma.
    Huang DQ; Hoang JK; Leong J; Riveiro-Barciela M; Maeda M; Yang JD; Accarino EV; Thin K; Trinh L; Cheung RC; Roberts LR; Buti M; Schwartz M; Nguyen MH
    Liver Int; 2021 Aug; 41(8):1922-1932. PubMed ID: 33713386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Hepatitis B Virus DNA Level and Follow-up Interval With Hepatocellular Carcinoma Recurrence.
    Wang W; Tian SL; Wang H; Shao CC; Wang YZ; Li YL
    JAMA Netw Open; 2020 Apr; 3(4):e203707. PubMed ID: 32338753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of Antiviral Therapy for Patients With Hepatitis B-Related Hepatocellular Carcinoma: A Nationwide Real-World US Study.
    Kudaravalli S; Kam LY; Huang DQ; Cheung R; Nguyen MH
    Clin Gastroenterol Hepatol; 2023 Dec; 21(13):3305-3313.e4. PubMed ID: 37805836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of clinical outcomes in chronic hepatitis B liver transplant candidates with and without hepatocellular carcinoma.
    Wong SN; Reddy KR; Keeffe EB; Han SH; Gaglio PJ; Perrillo RP; Tran TT; Pruett TL; Lok AS
    Liver Transpl; 2007 Mar; 13(3):334-42. PubMed ID: 17154401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
    Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
    World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Heavy Alcohol Intake and ALDH2 rs671 Polymorphism With Hepatocellular Carcinoma and Mortality in Patients With Hepatitis B Virus-Related Cirrhosis.
    Tsai MC; Yang SS; Lin CC; Wang WL; Hsu YC; Chen YS; Hu JT; Lin JY; Yu ML; Lin CW
    JAMA Netw Open; 2022 Jul; 5(7):e2223511. PubMed ID: 35877121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C.
    Hsu PY; Hsu CT; Yeh ML; Huang CF; Huang CI; Liang PC; Lin YH; Hsieh MY; Wei YJ; Hsieh MH; Dai CY; Lin ZY; Chen SC; Huang JF; Yu ML; Chuang WL
    Dig Dis Sci; 2020 Jul; 65(7):2120-2129. PubMed ID: 31722058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the Ability of the New Subclassification to Prognosticate Outcomes Following Hepatectomy for Patients with HBV-Related HCC.
    Tian Y; Lyu H; He Y; Kanduri HK
    J Gastrointest Cancer; 2019 Sep; 50(3):400-407. PubMed ID: 29512001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B and alcohol affect survival of hepatocellular carcinoma patients.
    Wong LL; Limm WM; Tsai N; Severino R
    World J Gastroenterol; 2005 Jun; 11(23):3491-7. PubMed ID: 15962361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival in Asian Americans after treatments for hepatocellular carcinoma: a seven-year experience at UCLA.
    Tong MJ; Chavalitdhamrong D; Lu DS; Raman SS; Gomes A; Duffy JP; Hong JC; Busuttil RW
    J Clin Gastroenterol; 2010 Mar; 44(3):e63-70. PubMed ID: 19745756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral therapy improves post-operative survival outcomes in patients with HBV-related hepatocellular carcinoma of less than 3 cm - A retrospective cohort study.
    Wang ZY; Tao QF; Wang ZH; Lin KY; Huang G; Yang Y; Zhou WP; Lau WY
    Am J Surg; 2020 Apr; 219(4):717-725. PubMed ID: 31266631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors predicting outcomes of hepatitis B-related cirrhosis patients with long-term antiviral therapy.
    Lin CL; Tseng KC; Chen KY; Liao LY; Kao JH
    J Formos Med Assoc; 2020 Oct; 119(10):1483-1489. PubMed ID: 32653388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes after hepatectomy of patients with positive HBcAb Non-B Non-C hepatocellular carcinoma compared to overt hepatitis B virus hepatocellular carcinoma.
    Wu SS; Shan QY; Xie WX; Chen B; Huang Y; Guo Y; Xie XY; Lu MD; Peng BG; Kuang M; Shen SL; Wang W
    Clin Transl Oncol; 2020 Mar; 22(3):401-410. PubMed ID: 31172445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term trends in chronic hepatitis B virus infection associated liver transplantation outcomes in the United States.
    Young K; Liu B; Bhuket T; Younossi Z; Saab S; Ahmed A; Wong RJ
    J Viral Hepat; 2017 Sep; 24(9):789-796. PubMed ID: 28273387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus-associated hepatocellular carcinoma in South Africa in the era of HIV.
    Maponga TG; Glashoff RH; Vermeulen H; Robertson B; Burmeister S; Bernon M; Omoshoro-Jones J; Ruff P; Neugut AI; Jacobson JS; Preiser W; Andersson MI
    BMC Gastroenterol; 2020 Jul; 20(1):226. PubMed ID: 32660431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral hepatitis B and hepatocellular carcinoma.
    Michielsen P; Ho E
    Acta Gastroenterol Belg; 2011 Mar; 74(1):4-8. PubMed ID: 21563647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical presentation and survival of Asian and non-Asian patients with HCV-related hepatocellular carcinoma.
    Yip B; Wantuck JM; Kim LH; Wong RJ; Ahmed A; Garcia G; Nguyen MH
    Dig Dis Sci; 2014 Jan; 59(1):192-200. PubMed ID: 24282055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.
    Shrestha SM; Shrestha S; Shrestha A; Tsuda F; Endo K; Takahashi M; Okamoto H
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1921-8. PubMed ID: 17914971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease.
    Wong CR; Njei B; Nguyen MH; Nguyen A; Lim JK
    Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1061-1069. PubMed ID: 28960360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of HBV DNA load on the safety and prognosis of systematic therapy in advanced hepatocellular carcinoma].
    Zheng XR; Peng JX; Song X; Liu B; Zhong C; Chen XY; Zhang BX; Peng L; Zhu KS; Xie C
    Zhonghua Yi Xue Za Zhi; 2024 Apr; 104(14):1160-1167. PubMed ID: 38583047
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.